Global DTP Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global DTP Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global DTP Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global DTP Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global DTP Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global DTP Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global DTP Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DTP Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DTP Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SANOFI PASTEUR, NOVARTIS, Vaxelis, GSK and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
DTP Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pertussis
Diphtheria
Tetanus
Market segment by Application
Hospital
Epidemic Prevention Station
Village Health Room
Major players covered
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTP Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DTP Vaccine, with price, sales, revenue and global market share of DTP Vaccine from 2018 to 2023.
Chapter 3, the DTP Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTP Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and DTP Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of DTP Vaccine.
Chapter 14 and 15, to describe DTP Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of DTP Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DTP Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pertussis
1.3.3 Diphtheria
1.3.4 Tetanus
1.4 Market Analysis by Application
1.4.1 Overview: Global DTP Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Epidemic Prevention Station
1.4.4 Village Health Room
1.5 Global DTP Vaccine Market Size & Forecast
1.5.1 Global DTP Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global DTP Vaccine Sales Quantity (2018-2029)
1.5.3 Global DTP Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 SANOFI PASTEUR
2.1.1 SANOFI PASTEUR Details
2.1.2 SANOFI PASTEUR Major Business
2.1.3 SANOFI PASTEUR DTP Vaccine Product and Services
2.1.4 SANOFI PASTEUR DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 SANOFI PASTEUR Recent Developments/Updates
2.2 NOVARTIS
2.2.1 NOVARTIS Details
2.2.2 NOVARTIS Major Business
2.2.3 NOVARTIS DTP Vaccine Product and Services
2.2.4 NOVARTIS DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 NOVARTIS Recent Developments/Updates
2.3 Vaxelis
2.3.1 Vaxelis Details
2.3.2 Vaxelis Major Business
2.3.3 Vaxelis DTP Vaccine Product and Services
2.3.4 Vaxelis DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Vaxelis Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK DTP Vaccine Product and Services
2.4.4 GSK DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India DTP Vaccine Product and Services
2.5.4 Serum Institute of India DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson DTP Vaccine Product and Services
2.6.4 Johnson & Johnson DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Merck Sharp & Dohme Corp
2.7.1 Merck Sharp & Dohme Corp Details
2.7.2 Merck Sharp & Dohme Corp Major Business
2.7.3 Merck Sharp & Dohme Corp DTP Vaccine Product and Services
2.7.4 Merck Sharp & Dohme Corp DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Sharp & Dohme Corp Recent Developments/Updates
2.8 Seqirus
2.8.1 Seqirus Details
2.8.2 Seqirus Major Business
2.8.3 Seqirus DTP Vaccine Product and Services
2.8.4 Seqirus DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Seqirus Recent Developments/Updates
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer DTP Vaccine Product and Services
2.9.4 Pfizer DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pfizer Recent Developments/Updates
2.10 Astrazeneca
2.10.1 Astrazeneca Details
2.10.2 Astrazeneca Major Business
2.10.3 Astrazeneca DTP Vaccine Product and Services
2.10.4 Astrazeneca DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Astrazeneca Recent Developments/Updates
2.11 astellas
2.11.1 astellas Details
2.11.2 astellas Major Business
2.11.3 astellas DTP Vaccine Product and Services
2.11.4 astellas DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 astellas Recent Developments/Updates
2.12 Emergent BioSolutions Inc
2.12.1 Emergent BioSolutions Inc Details
2.12.2 Emergent BioSolutions Inc Major Business
2.12.3 Emergent BioSolutions Inc DTP Vaccine Product and Services
2.12.4 Emergent BioSolutions Inc DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Emergent BioSolutions Inc Recent Developments/Updates
2.13 WALVAX
2.13.1 WALVAX Details
2.13.2 WALVAX Major Business
2.13.3 WALVAX DTP Vaccine Product and Services
2.13.4 WALVAX DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 WALVAX Recent Developments/Updates
2.14 Wuhan Institute of Biological Products Co.,Ltd.
2.14.1 Wuhan Institute of Biological Products Co.,Ltd. Details
2.14.2 Wuhan Institute of Biological Products Co.,Ltd. Major Business
2.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
2.14.4 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuhan Institute of Biological Products Co.,Ltd. Recent Developments/Updates
2.15 Chengdu Institute of Biological Products Co.,Ltd.
2.15.1 Chengdu Institute of Biological Products Co.,Ltd. Details
2.15.2 Chengdu Institute of Biological Products Co.,Ltd. Major Business
2.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
2.15.4 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Chengdu Institute of Biological Products Co.,Ltd. Recent Developments/Updates
3 Competitive Environment: DTP Vaccine by Manufacturer
3.1 Global DTP Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global DTP Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global DTP Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of DTP Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 DTP Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 DTP Vaccine Manufacturer Market Share in 2022
3.5 DTP Vaccine Market: Overall Company Footprint Analysis
3.5.1 DTP Vaccine Market: Region Footprint
3.5.2 DTP Vaccine Market: Company Product Type Footprint
3.5.3 DTP Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global DTP Vaccine Market Size by Region
4.1.1 Global DTP Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global DTP Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global DTP Vaccine Average Price by Region (2018-2029)
4.2 North America DTP Vaccine Consumption Value (2018-2029)
4.3 Europe DTP Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific DTP Vaccine Consumption Value (2018-2029)
4.5 South America DTP Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa DTP Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global DTP Vaccine Sales Quantity by Type (2018-2029)
5.2 Global DTP Vaccine Consumption Value by Type (2018-2029)
5.3 Global DTP Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global DTP Vaccine Sales Quantity by Application (2018-2029)
6.2 Global DTP Vaccine Consumption Value by Application (2018-2029)
6.3 Global DTP Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America DTP Vaccine Sales Quantity by Type (2018-2029)
7.2 North America DTP Vaccine Sales Quantity by Application (2018-2029)
7.3 North America DTP Vaccine Market Size by Country
7.3.1 North America DTP Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America DTP Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe DTP Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe DTP Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe DTP Vaccine Market Size by Country
8.3.1 Europe DTP Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe DTP Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific DTP Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific DTP Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific DTP Vaccine Market Size by Region
9.3.1 Asia-Pacific DTP Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific DTP Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America DTP Vaccine Sales Quantity by Type (2018-2029)
10.2 South America DTP Vaccine Sales Quantity by Application (2018-2029)
10.3 South America DTP Vaccine Market Size by Country
10.3.1 South America DTP Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America DTP Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa DTP Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa DTP Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa DTP Vaccine Market Size by Country
11.3.1 Middle East & Africa DTP Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa DTP Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 DTP Vaccine Market Drivers
12.2 DTP Vaccine Market Restraints
12.3 DTP Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of DTP Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of DTP Vaccine
13.3 DTP Vaccine Production Process
13.4 DTP Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DTP Vaccine Typical Distributors
14.3 DTP Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Tables and Figures
List of Tables
Table 1. Global DTP Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global DTP Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. SANOFI PASTEUR Basic Information, Manufacturing Base and Competitors
Table 4. SANOFI PASTEUR Major Business
Table 5. SANOFI PASTEUR DTP Vaccine Product and Services
Table 6. SANOFI PASTEUR DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. SANOFI PASTEUR Recent Developments/Updates
Table 8. NOVARTIS Basic Information, Manufacturing Base and Competitors
Table 9. NOVARTIS Major Business
Table 10. NOVARTIS DTP Vaccine Product and Services
Table 11. NOVARTIS DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. NOVARTIS Recent Developments/Updates
Table 13. Vaxelis Basic Information, Manufacturing Base and Competitors
Table 14. Vaxelis Major Business
Table 15. Vaxelis DTP Vaccine Product and Services
Table 16. Vaxelis DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Vaxelis Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK DTP Vaccine Product and Services
Table 21. GSK DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India DTP Vaccine Product and Services
Table 26. Serum Institute of India DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson DTP Vaccine Product and Services
Table 31. Johnson & Johnson DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 34. Merck Sharp & Dohme Corp Major Business
Table 35. Merck Sharp & Dohme Corp DTP Vaccine Product and Services
Table 36. Merck Sharp & Dohme Corp DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Sharp & Dohme Corp Recent Developments/Updates
Table 38. Seqirus Basic Information, Manufacturing Base and Competitors
Table 39. Seqirus Major Business
Table 40. Seqirus DTP Vaccine Product and Services
Table 41. Seqirus DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Seqirus Recent Developments/Updates
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer DTP Vaccine Product and Services
Table 46. Pfizer DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Pfizer Recent Developments/Updates
Table 48. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 49. Astrazeneca Major Business
Table 50. Astrazeneca DTP Vaccine Product and Services
Table 51. Astrazeneca DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Astrazeneca Recent Developments/Updates
Table 53. astellas Basic Information, Manufacturing Base and Competitors
Table 54. astellas Major Business
Table 55. astellas DTP Vaccine Product and Services
Table 56. astellas DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. astellas Recent Developments/Updates
Table 58. Emergent BioSolutions Inc Basic Information, Manufacturing Base and Competitors
Table 59. Emergent BioSolutions Inc Major Business
Table 60. Emergent BioSolutions Inc DTP Vaccine Product and Services
Table 61. Emergent BioSolutions Inc DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Emergent BioSolutions Inc Recent Developments/Updates
Table 63. WALVAX Basic Information, Manufacturing Base and Competitors
Table 64. WALVAX Major Business
Table 65. WALVAX DTP Vaccine Product and Services
Table 66. WALVAX DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. WALVAX Recent Developments/Updates
Table 68. Wuhan Institute of Biological Products Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Wuhan Institute of Biological Products Co.,Ltd. Major Business
Table 70. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
Table 71. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Wuhan Institute of Biological Products Co.,Ltd. Recent Developments/Updates
Table 73. Chengdu Institute of Biological Products Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Institute of Biological Products Co.,Ltd. Major Business
Table 75. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product and Services
Table 76. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Chengdu Institute of Biological Products Co.,Ltd. Recent Developments/Updates
Table 78. Global DTP Vaccine Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 79. Global DTP Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global DTP Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in DTP Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and DTP Vaccine Production Site of Key Manufacturer
Table 83. DTP Vaccine Market: Company Product Type Footprint
Table 84. DTP Vaccine Market: Company Product Application Footprint
Table 85. DTP Vaccine New Market Entrants and Barriers to Market Entry
Table 86. DTP Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global DTP Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 88. Global DTP Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 89. Global DTP Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global DTP Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global DTP Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global DTP Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 94. Global DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 95. Global DTP Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global DTP Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global DTP Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global DTP Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 100. Global DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 101. Global DTP Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global DTP Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global DTP Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global DTP Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 106. North America DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 107. North America DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 108. North America DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 109. North America DTP Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 110. North America DTP Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 111. North America DTP Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America DTP Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 114. Europe DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 115. Europe DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 116. Europe DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 117. Europe DTP Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 118. Europe DTP Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 119. Europe DTP Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe DTP Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 122. Asia-Pacific DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 123. Asia-Pacific DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 124. Asia-Pacific DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 125. Asia-Pacific DTP Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 126. Asia-Pacific DTP Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 127. Asia-Pacific DTP Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific DTP Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 130. South America DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 131. South America DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 132. South America DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 133. South America DTP Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 134. South America DTP Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 135. South America DTP Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America DTP Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa DTP Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 138. Middle East & Africa DTP Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 139. Middle East & Africa DTP Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 140. Middle East & Africa DTP Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 141. Middle East & Africa DTP Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 142. Middle East & Africa DTP Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 143. Middle East & Africa DTP Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa DTP Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. DTP Vaccine Raw Material
Table 146. Key Manufacturers of DTP Vaccine Raw Materials
Table 147. DTP Vaccine Typical Distributors
Table 148. DTP Vaccine Typical Customers
List of Figures
Figure 1. DTP Vaccine Picture
Figure 2. Global DTP Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global DTP Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Pertussis Examples
Figure 5. Diphtheria Examples
Figure 6. Tetanus Examples
Figure 7. Global DTP Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global DTP Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Epidemic Prevention Station Examples
Figure 11. Village Health Room Examples
Figure 12. Global DTP Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global DTP Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global DTP Vaccine Sales Quantity (2018-2029) & (Units)
Figure 15. Global DTP Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global DTP Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global DTP Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of DTP Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 DTP Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 DTP Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global DTP Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global DTP Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America DTP Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe DTP Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific DTP Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America DTP Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa DTP Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global DTP Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global DTP Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global DTP Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global DTP Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America DTP Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America DTP Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe DTP Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe DTP Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific DTP Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific DTP Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America DTP Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America DTP Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa DTP Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa DTP Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa DTP Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa DTP Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa DTP Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. DTP Vaccine Market Drivers
Figure 75. DTP Vaccine Market Restraints
Figure 76. DTP Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of DTP Vaccine in 2022
Figure 79. Manufacturing Process Analysis of DTP Vaccine
Figure 80. DTP Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Companies Mentioned
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets